20 November, 2023 | Online
Chairs: Dr. Carolina Arez Constant (Lisboa, Portugal), Dr. Ahmad Kantar (Bergamo, Italy)
Speakers: Ms. Zena Powell (Aylesbury, United Kingdom), Prof. Andrew Bush (London, United Kingdom), Prof. James D. Chalmers (Dundee, United Kingdom)
Fees: Free for ERS members / €10 for non-members
Find out more about becoming a member
Non-CF Bronchiectasis is a clinical syndrome of recurrent or persistent wet/productive cough, lower airway infection and/or inflammation, and abnormal bronchial dilatation on chest computed tomography scans. It is a heterogenous chronic pulmonary disorder with many risk factors and aetiologies.
Previously considered irreversible, current data shows that paediatric non-CF bronchiectasis might be reversible over time. Achieving this goal requires early disease recognition leading to appropriate investigations to both diagnose and manage bronchiectasis. Evaluation for treatable underlying causes and effective management are therefore important.
Children/adolescents also require developmentally appropriate care, support and supervision from their parents. Those with untreated non-CF bronchiectasis symptoms from childhood have worse disease and a poorer prognosis. Non-CF Bronchiectasis is still one of the most neglected lung disorders, with high individual disease burden, economic cost and poor quality of life for children/adolescents and their parents. Also, there are large disparities in the standards of care and outcomes between bronchiectasis and other chronic lung diseases.
This webinar will provide an update on current literature on non-CF bronchiectasis and the needs for early disease recognition, prevention and transition from paediatric to adult care.
Moreover, the webinar will offer an opportunity to examine patients experiences, attitudes, preferences, needs, and expectations in patients non-CF bronchiectasis. Patients' perspectives and health goals are at the heart of the care process.
These arguments are among the objectives of the ERS-CRC - Child-BEAR-net (Children's Bronchiectasis Education Advocacy and Research Network).
The webinar will include a patient testimonial, lectures, interactive discussions with participants and two case presentations.
After following this webinar, participants should be able to:
An application for accreditation of this webinar has been made to the European Board for Accreditation in Pneumology (EBAP) for 1 CME credit per 1-hour attendance. If accredited, the CME credit will be granted upon attendance of at least 60 minutes during the live webinar only.
A webinar closely simulates a lecture-based teaching experience. The speaker can interact with the audience, just as in a classroom setting. During the webinar, you will be asked to share your opinion on issues related to the topic using interactive polls.
All participants will be able to hear the lecturer and see the slides throughout the presentation. As a participant you will be able to pose questions or discuss ideas with the other participants via the text chat facility and the speaker will respond to the questions via the microphone.
More information will be communicated in due course.